Copyright Reports & Markets. All rights reserved.

Global 5-in-1 DTaP-Hib-IPV Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of 5-in-1 DTaP-Hib-IPV Vaccine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 8-month
    • 1.3.3 18-month
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Community
  • 1.5 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size & Forecast
    • 1.5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (2018-2029)
    • 1.5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sanofi Pasteur
    • 2.1.1 Sanofi Pasteur Details
    • 2.1.2 Sanofi Pasteur Major Business
    • 2.1.3 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Product and Services
    • 2.1.4 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sanofi Pasteur Recent Developments/Updates

3 Competitive Environment: 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer

  • 3.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Revenue by Manufacturer (2018-2023)
  • 3.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
    • 3.4.2 Top 6 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
  • 3.5 5-in-1 DTaP-Hib-IPV Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 5-in-1 DTaP-Hib-IPV Vaccine Market: Region Footprint
    • 3.5.2 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Type Footprint
    • 3.5.3 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
    • 4.1.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
    • 4.1.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
    • 4.1.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2018-2029)
  • 4.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
  • 4.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
  • 4.4 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
  • 4.5 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
  • 4.6 Middle East and Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
  • 5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2018-2029)
  • 5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
  • 6.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2018-2029)
  • 6.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2029)

7 North America

  • 7.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
  • 7.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
  • 7.3 North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
    • 7.3.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
    • 7.3.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
  • 8.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
  • 8.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
    • 8.3.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
  • 10.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
  • 10.3 South America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
    • 10.3.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
    • 10.3.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 5-in-1 DTaP-Hib-IPV Vaccine Market Drivers
  • 12.2 5-in-1 DTaP-Hib-IPV Vaccine Market Restraints
  • 12.3 5-in-1 DTaP-Hib-IPV Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of 5-in-1 DTaP-Hib-IPV Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of 5-in-1 DTaP-Hib-IPV Vaccine
  • 13.3 5-in-1 DTaP-Hib-IPV Vaccine Production Process
  • 13.4 5-in-1 DTaP-Hib-IPV Vaccine Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 5-in-1 DTaP-Hib-IPV Vaccine Typical Distributors
  • 14.3 5-in-1 DTaP-Hib-IPV Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global 5-in-1 DTaP-Hib-IPV Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    A 5-in-1 DTaP-Hib-IPV vaccine is an inactivated one that is injected to simultaneously protect against five infectious diseases: diphtheria, tetanus, pertussis, poliomyelitis and haemophilus influenzae type b.
    The Global Info Research report includes an overview of the development of the 5-in-1 DTaP-Hib-IPV Vaccine industry chain, the market status of Hospital (8-month, 18-month), Community (8-month, 18-month), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of 5-in-1 DTaP-Hib-IPV Vaccine.
    Regionally, the report analyzes the 5-in-1 DTaP-Hib-IPV Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global 5-in-1 DTaP-Hib-IPV Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the 5-in-1 DTaP-Hib-IPV Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the 5-in-1 DTaP-Hib-IPV Vaccine industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 8-month, 18-month).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the 5-in-1 DTaP-Hib-IPV Vaccine market.
    Regional Analysis: The report involves examining the 5-in-1 DTaP-Hib-IPV Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the 5-in-1 DTaP-Hib-IPV Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to 5-in-1 DTaP-Hib-IPV Vaccine:
    Company Analysis: Report covers individual 5-in-1 DTaP-Hib-IPV Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards 5-in-1 DTaP-Hib-IPV Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Community).
    Technology Analysis: Report covers specific technologies relevant to 5-in-1 DTaP-Hib-IPV Vaccine. It assesses the current state, advancements, and potential future developments in 5-in-1 DTaP-Hib-IPV Vaccine areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the 5-in-1 DTaP-Hib-IPV Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    5-in-1 DTaP-Hib-IPV Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    8-month
    18-month
    Market segment by Application
    Hospital
    Community
    Major players covered
    Sanofi Pasteur
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe 5-in-1 DTaP-Hib-IPV Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of 5-in-1 DTaP-Hib-IPV Vaccine, with price, sales, revenue and global market share of 5-in-1 DTaP-Hib-IPV Vaccine from 2018 to 2023.
    Chapter 3, the 5-in-1 DTaP-Hib-IPV Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the 5-in-1 DTaP-Hib-IPV Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and 5-in-1 DTaP-Hib-IPV Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of 5-in-1 DTaP-Hib-IPV Vaccine.
    Chapter 14 and 15, to describe 5-in-1 DTaP-Hib-IPV Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now